Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
Price:
90.61
USD
Market Closed
Market Cap:
$4.6B
Relative Value
The Relative Value of one
LABFF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 90.61 USD,
Laboratorios Farmaceuticos ROVI SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LABFF Relative Value
HIDDEN
Multiples Across Competitors
LABFF Competitors Multiples
Laboratorios Farmaceuticos ROVI SA Competitors
Laboratorios Farmaceuticos ROVI SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
|
3.9B USD | 5.4 | 32.5 | 21 | 24.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD | 15.1 | 47.7 | 32.2 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF | 4.7 | 30.5 | 12.9 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP | 5.5 | 31.3 | 17.3 | 24.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF | 5.5 | 22 | 13.6 | 17.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.9 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
